Theorem Clinical Research and Gallus Biopharmaceuticals, LLC Announce an Exclusive Partnership to Help Companies Accelerate Their Research, Development and Manufacturing of Biopharmaceuticals

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research (Theorem) has entered an exclusive partnership with Gallus BioPharmaceuticals (Gallus).

In this partnership, Gallus will provide process development and clinical and commercial supply for mammalian cell-based biopharmaceutical products to Theorem’s customers. In return, Theorem will offer contract research services to Gallus’ customers to increase both companies’ global reach and accelerate their customers’ products through the clinic to market.

Back to news